GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aprinoia Therapeutics Inc (NAS:APRI) » Definitions » Operating Cash Flow per Share

Aprinoia Therapeutics (Aprinoia Therapeutics) Operating Cash Flow per Share : $-0.46 (TTM As of Jun. 2023)


View and export this data going back to 2050. Start your Free Trial

What is Aprinoia Therapeutics Operating Cash Flow per Share?

Aprinoia Therapeutics's operating cash flow per share for the six months ended in Jun. 2023 was $-0.20. Aprinoia Therapeutics's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.46.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Aprinoia Therapeutics's Operating Cash Flow per Share or its related term are showing as below:

APRI's 3-Year OCF Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 3.7
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Aprinoia Therapeutics Operating Cash Flow per Share Historical Data

The historical data trend for Aprinoia Therapeutics's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aprinoia Therapeutics Operating Cash Flow per Share Chart

Aprinoia Therapeutics Annual Data
Trend Dec21 Dec22
Operating Cash Flow per Share
-0.87 -0.62

Aprinoia Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23
Operating Cash Flow per Share - -0.35 -0.27 -0.20

Competitive Comparison of Aprinoia Therapeutics's Operating Cash Flow per Share

For the Biotechnology subindustry, Aprinoia Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aprinoia Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aprinoia Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Aprinoia Therapeutics's Price-to-Operating-Cash-Flow falls into.


Aprinoia Therapeutics Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Aprinoia Therapeutics's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (A: Dec. 2022 )=Cash Flow from Operations (A: Dec. 2022 )/Shares Outstanding (Diluted Average) (A: Dec. 2022 )
=-17.237/27.829
=-0.62

Aprinoia Therapeutics's Operating Cash Flow per Share for the quarter that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (Q: Jun. 2023 )=Cash Flow from Operations (Q: Jun. 2023 )/Shares Outstanding (Diluted Average) (Q: Jun. 2023 )
=-5.451/27.829
=-0.20

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprinoia Therapeutics Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Aprinoia Therapeutics's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Aprinoia Therapeutics (Aprinoia Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aprinoia Therapeutics Inc (NAS:APRI) » Definitions » Operating Cash Flow per Share
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.

Aprinoia Therapeutics (Aprinoia Therapeutics) Headlines

No Headlines